Nrx Pharmaceuticals, Inc. · NASDAQ:NRXP
Nrx Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 45 institutions reported holding Nrx Pharmaceuticals, Inc., 26.9% of its shares. Largest: B Group, Inc., Vanguard and Ameriprise. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Nrx Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| B Group, Inc. | 4.09M | 9.5% | +1.09M | Aug 14, 2026 |
| Vanguard | 1.81M | 4.2% | +477K | Aug 13, 2026 |
| Ameriprise | 929K | 2.1% | new | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 894K | 2.1% | new | Aug 14, 2026 |
| Citadel | 680K | 1.6% | new | Aug 14, 2026 |
| AdvisorShares Investments LLC | 659K | 1.5% | +239K | Aug 11, 2026 |
| Commonwealth Equity Services, LLC | 454K | 1.0% | +56,987 | Jul 29, 2026 |
| UBS | 423K | 0.98% | +398K | Aug 13, 2026 |
| Geode Capital | 315K | 0.73% | +4,547 | Aug 12, 2026 |
| BlackRock | 220K | 0.51% | +121K | Aug 7, 2026 |